The Cancer Diagnostic Market was valued at USD 21.38 billion in 2023 and is projected to reach a market size of USD 45.81 billion by the end of 2030. Over the forecast period of 2024-2030, the market is estimated to grow at a CAGR of 11.5%.
Any cancer that begins in the eye is referred to as Ophthalmic Cancer. When cells begin to grow uncontrollably, cancer develops. Melanoma is the most common type of cancer in the eye, although a variety of cancers affect the other components of the eye. Eye Cancer is a rare type of cancer that affects three elements of the eye: the eyeballs, the orbit, and the adnexa. Cancer diagnostics is the method of identifying numerous proteins, biomarkers, and symptoms that lead to the presence of a cancerous tumor in patients. The detection of particular biomarkers and proteins that are usual in cancer disorders causes the diagnosis process. Detecting cancer involves applying particular techniques and devices used in its diagnosis. Imaging, laboratory tests, tumor biopsy, surgery, endoscopic examination, and genetic testing are all different types of possible cancer diagnostic techniques. Technological advancements in diagnostic tests are expected to accelerate industry growth as healthcare professionals focus on developing effective screening and treatment solutions to check prevalence levels. Different healthcare professionals primarily highlight on developing effective screening and treatment solutions to evaluate the prevalence levels.
Key Market Insights:
Over 100 varieties of cancers have been identified. According to Cancer Research UK, worldwide over 14.1 million new cancer cases were registered, which is anticipated to increase in future years. Furthermore, as per the report published in the American Society of Clinical Oncology, over 3500 patients in the US were diagnosed with primary intraocular cancer.
Blue Earth Diagnostics received the FDA’s permission for high-affinity radio hybrid (rh) Prostate-Specific Membrane Antigen (PSMA)-targeted PET imaging agent, POSLUMA, for prostate cancer detection and localization. It's based on innovative radio hybrid technology, offering accurate imaging and potential therapeutic applications.
Quest Diagnostics bought Haystack Oncology in an all-cash deal to expand MRD testing services, initially targeting colorectal, breast, and lung cancers, targeting to enhance patient outcomes through early MRD detection after treatment.
Ophthalmic Cancer Diagnostic Market Drivers:
Accelerated developments of Diagnostic Testing Techniques
Technological advancements in diagnostic testing are anticipated to boost market growth during the forecast period. For example, Hologic, Inc. announced the commercial access of the Genius Digital Diagnostics System in Europe in 2021. The next-generation ophthalmic cancer screening system includes deep learning-based AI and innovative volumetric imaging technology to help detect Ophthalmic cancer cells and pre-cancerous lesions in women. Thus, this is estimated to boost market growth.
Developing Strategic Collaborations Associated with Cancer Diagnostics
There is a growth in collaborations and acquisitions associated with cancer diagnostics products. For example, the Precision Cancer Consortium (PCC) collaborated with pharmaceutical companies in 2022 by allowing permission for comprehensive testing for all cancer patients worldwide. The PCC runs many initiatives to widen patient access to precision diagnostics via wide-ranging genomic testing, including NGS. Thus, this pushes the market growth
Rise in the number of private diagnostic centers
The number of private diagnostic centers is rising across the globe as there is a growing demand for diagnostic imaging procedures and an increasing burden on public hospitals due to the restricted number of imaging modalities at their disposal. In January 2021, FUJIFILM Corporation launched NURA, a medical screening center focusing on cancer screening in Bangalore, India. This medical screening center is operated by FUJIFILM DKH LLP (FUJIFILM DKH) and Dr. Kutty’s Healthcare (DKH). FUJIFILM DKH LLP (FUJIFILM DKH) is a joint venture of FUJIFILM and Dr. Kutty’s Healthcare (DKH), which operates hospitals and screening centers in India and the Middle East
Ophthalmic Cancer Diagnostic Market Restraints and Challenges:
Diagnostic Imaging is expensive
Many hospitals in underdeveloped and developing countries cannot invest in diagnostic imaging equipment because of high costs and budgetary constraints. However, because of the rising demand for diagnostic imaging processes in these countries, the hospitals that cannot afford to purchase new and advanced imaging systems favor rebuilt ones. Thus, this element restraints the market growth.
Heightened adoption of refurbished diagnostic imaging systems
Many hospitals in developing economies cannot invest in diagnostic imaging equipment due to their higher cost, poor reimbursement rates, and budgetary constraints. However, due to the high necessity for diagnostic imaging procedures in these nations, hospitals that cannot afford to spend on new imaging systems prefer to opt for refurbished ones. Refurbished systems are charged lower than new systems and are approximately in the range of 40% to 60% of the original price of the equipment.
Due to this, many market leaders are now supporting refurbished devices through various programs. For example, Siemens’ Medical Proven Excellence Program, GE Healthcare’s Gold Seal Program, and Philips’ Diamond Select Program are a few noteworthy global refurbishing programs that encourage the utilization of refurbished diagnostic imaging systems.
Ophthalmic Cancer Diagnostic Market Opportunities:
Rising number of awareness programs by major Organizations
An increasing number of programs to spread awareness about malignant tumor screening in numerous organizations is a key factor responsible for the increased demand for diagnostic products globally. Numerous nations have undertaken several measures to increase screening for early screening and aid patients. For example, the Indian government has incorporated the Prime Minister's National Relief Fund and Ayushman Bharat for patients demanding treatment assistance. Thus, this factor pushes market growth.
Growing number of Diagnostic Testing Kit Launches for Cancer
There has been an increasing number of testing kit launches that are assisting in the market growth. For example, Sysmex Corporation launched the ipsogen JAK2 DX reagent in 2020. It is a gene testing kit that measures the JAK2V617F mutation quantitatively, which is widely utilized for screening blood cancers. Moreover, the product gained health insurance coverage, becoming Japan's first diagnostic product to be insured in 2020. Thus, this factor aids in the growth of the market.
OPHTHALMIC CANCER DIAGNOSTIC MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2023 - 2030 |
|
Base Year |
2023 |
|
Forecast Period |
2024 - 2030 |
|
CAGR |
11.5% |
|
Segments Covered |
By Type, End-User, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
AbbVie Inc., Amgen Inc., Astra Zeneca plc., Bayer AG., Bristol-Myers Squibb Company., Carl Zeiss AG., Castle Biosciences, Inc., Eli Lilly & Co. |
Imaging Testing
Biomarkers Testing
In Vitro Diagnostic Testing
Biopsy
Others
The Imaging Segment may dominate the segment during the estimated period. With a 34.2% market share in 2023, the biopsy category led the market and is expected to retain its dominance throughout the forecast period. Modalities used in imaging like computed Tomography (CT) scans and Magnetic Resonance Imaging (MRI) are quick, non-invasive, and painless diagnostic methods. Imaging helps in cancer staging, as do prognostic and therapy system monitoring of metabolic and functional information. Due to these benefits, the use of imaging modalities in cancer screening programs has significantly grown. Worldwide, the use of sophisticated imaging tests, including such as multi-photon microscopy and magnetic resonance imaging, is rising. The various imaging modalities, in conjunction with other genetic and laboratory testing, are employed as evidential tests in detecting a range of cancer forms, aiding in the selection of a suitable treatment strategy. These factors are expected to drive the Imaging segment at an 8.0% CAGR throughout the forecast period.
Diagnostic Centres
Hospitals and Clinics
Research Institutes
Others
Diagnostic Centres segment dominated every other segment in 2023 with a share of 51.84%. Diagnostic laboratories are expected to represent significant growth over the forecast period owing to enhanced testing and the availability of resources for performing tests. There has been a better reliance of hospitals on diagnostic laboratories for testing & evaluation, which further leads to escalated growth. Increased consciousness about personalized medicine, technological advancements, and development in demand for affordable services are some of the major factors expected to drive the segment growth. Another major element boosting segment growth is a rise in government initiatives to offer various facilities, such as compensation for diagnostic tests. In addition, regulatory authorities are undertaking initiatives to update clinical laboratory diagnostic services and ease the process of diagnosis.
North America
Asia-Pacific
Europe
South America
Middle East and Africa
In terms of market share and revenue, the North American market is anticipated to be the most lucrative market for cancer diagnostics during the forecast period. In 2023, the regional cancer diagnostics market blossomed with a revenue share of 38.9%. One of the primary elements propelling the diagnostics industry in the region is the presence of several biotechnology and medical device firms. North America is likely to maintain its lead over the projection period due to increased spending for Research and Development initiatives and the widespread use of new technology.
During the estimated period, Asia Pacific is expected to record a CAGR of 6.9%. In the future years, the Asia Pacific area is expected to be one of the emerging regions for cancer diagnostics. Due to a big patient pool, the approachability to experienced technicians at a reduced cost, and a clear regulatory environment encouraging quicker product approvals, Asia Pacific is likely to display expanded growth shortly. In addition, the burgeoning medical tourism business in economies like China, India, and Malaysia is likely to grow the demand for cancer diagnosis and treatment screening.
COVID-19 Impact Analysis of the Ophthalmic Cancer Diagnostic Market:
The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business ceases. The closure of various plants and factories has impacted the global supply chains and negatively affected the manufacturing, delivery schedules, and sales of products in the global market. Some companies have already announced possible delays in the delivery of products and slump in future sales of their products. There is a big change in demand for Eye cancer drugs and therapeutics because of the pandemic situation and lockdown scenes so people cannot move out of their homes and cannot receive their treatments which ultimately affects the demand for Eye Cancer therapeutics and medications.
Latest Trends:
Technological advancements in Artificial Intelligence (AI) For Cancer Diagnostics Devices Market
The AI-based cancer detection system is an emerging trend in the Eye cancer diagnostics market. AI aids in upgrading the accuracy of image detection in diagnostic processes such as Eye cancer and lung cancer diagnostics, by detecting cancers in their initial stages. AI also decreases the instances of false positives in lung cancer screening, thus, improving lung cancer detection accuracy. For example, researchers at the Naval Medical Center San Diego and Google's AI research division Google AI developed a trustworthy solution consisting of cancer-detecting algorithms used for autonomous evaluation of lymph node biopsies. This AI solution improved the accuracy of metastatic breast cancer detection to 99%.
Key companies operating in the cancer diagnostic device market are eyeing the development of technology with artificial intelligence (AI), such as Qai Prostate, to earn a competitive edge in the market. Qai Prostate is used as a cancer diagnostic device for prostate cancer diagnosis. For example, In March 2023, Qritive, a Singapore-based company that develops AI-powered diagnostic techniques for pathologists, launched Qai Prostate. QAi Prostate is a modernized artificial intelligence (AI)-powered prostate cancer diagnosis tool. QAi Prostate utilizes machine learning algorithms to precisely identify and classify malignant and benign areas in prostate tissue samples. This tool is designed to a pathologists detect prostate cancer and differentiate between malignant and benign areas in prostate tissue samples.
Key Players:
AbbVie Inc.
Amgen Inc.,
Astra Zeneca plc.
Bayer AG.
Bristol-Myers Squibb Company.
Carl Zeiss AG.
Castle Biosciences, Inc.
Eli Lilly & Co.
Recent Developments
In 2022, Precipio, Inc. signed a distribution agreement for Heme Screen with a major distribution partner in the U.S. The company continues its Heme Screen distribution expansion strategy of a multi-pronged method by focusing on physician-owned laboratories, national and regional hospital networks, and reference labs.
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
The Cancer Diagnostic Market was valued at USD 21.38 billion in 2023 and is projected to reach a market size of USD 45.81 billion by the end of 2030. Over the forecast period of 2024-2030, the market is estimated to grow at a CAGR of 11.5%.
The development in testing techniques and collaborations among players is propelling the Ophthalmic Cancer Diagnostic Market.
Ophthalmic Cancer Diagnostic Market is segmented based on Type, End-User, and Region.
North America is the most dominant region for the Ophthalmic Cancer Diagnostic Market.
AbbVie Inc., Amgen Inc., Astra Zeneca plc., Bayer AG., and Bristol-Myers Squibb Company are a few of the key players operating in the Ophthalmic Cancer Diagnostic Market.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
